Morning Overview

Drinking beetroot juice just reshaped the mouth bacteria of older adults — quietly lowering their blood pressure as a cheap vegetable does the work of a pill

In June 2026, a research team at Queen Mary University of London published results from one of the more unusual cardiovascular trials in recent memory. They asked adults between 67 and 79 years old to drink concentrated beetroot juice every day for two weeks, then checked what had changed inside their mouths. Not their teeth or gums, but the bacteria colonizing their tongues and cheeks. The bacterial communities had shifted, and the shift pointed in a direction that cardiovascular researchers have been chasing for years: toward greater nitric oxide production, the body’s own mechanism for relaxing blood vessels and lowering blood pressure.

The finding, published in Free Radical Biology and Medicine, emerged from a double-blind crossover trial, a design in which every participant cycles through the real intervention, a placebo, and a comparison condition (in this case, antiseptic mouthwash), with washout periods in between. Because each person serves as their own control, the format strips away much of the individual variation that muddies nutrition research. The results were consistent: nitrate-rich beetroot juice reshaped the oral microbiome in measurable, repeatable ways.

What the bacteria are actually doing

To understand why mouth bacteria matter for blood pressure, you need to know about a metabolic loop that most people have never heard of: the enterosalivary nitrate-nitrite-nitric oxide pathway. When you eat nitrate-rich foods like beetroot, spinach, or arugula, your body absorbs the nitrate in the gut, then concentrates it in saliva through the salivary glands. Specific bacteria on the tongue, particularly species of Neisseria, reduce that nitrate into nitrite. Once swallowed, nitrite converts to nitric oxide in the acidic environment of the stomach and enters the bloodstream, where it signals blood vessel walls to relax. The result: lower vascular resistance and, potentially, lower blood pressure.

A separate crossover trial, this one focused on older adults already taking blood pressure medication, found that four weeks of beetroot juice increased Neisseria species and decreased Veillonella species in the oral microbiome. That trade matters. Neisseria bacteria are among the most efficient nitrate reducers in the human mouth; Veillonella contributes far less to that conversion. Notably, the same trial found no significant changes in the gut microbiome, suggesting the effect is specific to the oral cavity, right where the nitrate-to-nitrite conversion chain begins.

Earlier mechanistic work, also published in Free Radical Biology and Medicine, had already established that the nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood pressure in humans. That 2018 study helped reframe oral bacteria not as passive bystanders in cardiovascular health but as active participants. Network-level analyses of nitrate-sensitive bacterial communities in older adults have since shown stable relationships between oral bacterial modules and cardiovascular indices across both nitrate and placebo conditions, reinforcing that these microbial patterns are consistent and measurable rather than statistical noise.

The practical appeal and the catch

Concentrated beetroot juice costs a few dollars per serving. It requires no prescription. And the bacterial shift it produces targets a metabolic pathway that weakens with age: nitric oxide production naturally declines as people get older, contributing to the stiffening of arteries and the gradual rise in blood pressure that clinicians see in aging populations. For older adults already managing hypertension with medication, beetroot juice could, in principle, offer a complementary lever of control.

In the published trials, intervention doses typically corresponded to roughly one to two cups of concentrated beetroot juice per day, delivering a meaningful nitrate load without approaching harmful levels. Participants tolerated the regimen well. The most commonly reported side effects were beet-colored urine and stool, both harmless. That safety profile, combined with consistent microbiome shifts across multiple studies, underpins growing interest in beetroot juice as a low-cost adjunct to standard care.

But here is the catch. A randomized controlled trial in older adults with hypertension, published in Food & Function, found that four weeks of beetroot juice supplementation altered nitrate metabolism and reshaped the oral microbiome, yet did not produce sustained improvements in vascular function or blood pressure in that cohort. The biological machinery moved. The blood pressure readings did not.

That result sits in direct tension with an earlier phase 2 trial led by Vikas Kapil and colleagues at Queen Mary University of London, published in the American Heart Association journal Hypertension in 2015, which reported that dietary nitrate from beetroot juice produced sustained blood pressure reductions in hypertensive patients over four weeks. The discrepancy between these two well-designed trials has not been fully resolved. Possible explanations include differences in participant age, baseline vascular health, beetroot juice concentration, and the degree to which each person’s oral bacteria were already primed to convert nitrate efficiently before the trial began.

Why some people respond and others do not

One hypothesis gaining traction among researchers is that the magnitude of blood pressure response depends less on any single bacterial genus and more on the overall activity level of nitrate-reducing enzymes already present in a person’s saliva. If baseline salivary nitrite reductase activity varies widely among older adults, and early evidence suggests it does, that variation alone could explain why some people see clear blood pressure benefits from beetroot juice while others see none. No published trial has yet isolated this variable with enough precision to confirm or rule it out, but it remains one of the more promising avenues for future work.

The absence of participant-level blood pressure readings from the 67-to-79 age group in the newest crossover trial also leaves a gap. The microbiome data are robust, but the direct cardiovascular payoff in that specific age band has not been reported in granular detail. Readers should treat the blood pressure claim as supported by biological mechanism and by some trial data, but not yet confirmed across all relevant populations.

Durability is another open question. Most interventions lasted between two and four weeks. Researchers do not yet know whether the microbiome changes plateau, deepen, or fade with months of continuous use, or how quickly the oral ecosystem reverts to baseline after someone stops drinking beetroot juice. Long-term adherence presents its own challenge: concentrated beetroot juice has a strong, earthy flavor that some older adults find unpleasant, and if the perceived benefits are subtle, motivation to continue may wane.

It is also worth noting that beetroot is not the only dietary source of nitrate. Leafy greens like spinach, arugula, and lettuce deliver comparable nitrate loads per serving. The research focus on beetroot juice reflects its convenience as a standardized, measurable intervention in clinical trials, not necessarily its superiority over a salad. For people who dislike beets, a nitrate-rich diet built around greens may produce similar oral microbiome effects, though this has been less rigorously tested.

What beetroot juice can and cannot do for blood pressure in 2026

The strongest layer of evidence is the microbiome data. Multiple crossover trials with placebo controls consistently show that nitrate-rich beetroot juice shifts oral bacterial communities in a direction that favors nitric oxide production. The increase in Neisseria and decrease in Veillonella have been observed across studies, and the intestinal microbiome’s stability during the same interventions adds confidence that the oral effect is real and specific.

The blood pressure layer is where the evidence fractures. One well-designed trial shows sustained reductions. Another, in a similar population, does not. The most honest reading is that beetroot juice reliably changes the mouth’s bacterial profile in ways that should, based on known biology, support lower blood pressure. Whether it actually does so in a clinically meaningful and lasting way for any given person depends on factors researchers have not yet pinned down.

For anyone considering adding beetroot juice alongside existing blood pressure medication, the risk profile is low but not zero. Beetroot is high in oxalates, which may be a concern for people with a history of kidney stones. Its natural sugars can be relevant for those closely managing blood glucose. It will not replace prescribed medication, and no trial has tested it as a standalone substitute for antihypertensive drugs.

In practical terms, older adults who are curious should treat beetroot juice as a potential adjunct, not a cure. Any trial run is best done in coordination with a clinician, with home blood pressure readings tracked over several weeks and medication doses left unchanged unless a healthcare professional advises otherwise. If numbers improve modestly and side effects are manageable, continuing may make sense. If no change appears, the likely explanation is not that the science is wrong but that the individual’s microbiome and vascular system are less responsive to this particular intervention.

What is firmly established, as of mid-2026, is that a simple dietary change can measurably reshape the oral microbiome and activate a key cardiovascular pathway. What remains to be clarified is how reliably that microbial shift translates into lower numbers on the blood pressure cuff, and for whom. Larger, longer trials are needed. Until they arrive, beetroot juice occupies a genuinely interesting middle ground: more than a wellness trend, not yet a proven therapy, and one of the clearest illustrations in modern nutrition science of how the bacteria living in our mouths quietly influence the health of our hearts.

More from Morning Overview

*This article was researched with the help of AI, with human editors creating the final content.


More in Health